Description

Ibandronic Acid Concentrate for Infusions 1 mg/ml. 6 ml

Ingredients

Each ml contains 1 mg of Ibandronic acid.

Dosage

The recommended dosage is determined by a healthcare professional based on individual needs. It is typically administered as an intravenous infusion over a specific period.

Indications

Ibandronic acid concentrate for infusions is indicated for the treatment of osteoporosis in postmenopausal women. It helps in reducing the risk of fractures and improving bone density.

Contraindications

Do not use Ibandronic acid if you have low levels of calcium in the blood, severe kidney disease, or if you are allergic to bisphosphonates. Consult your healthcare provider for more information.

Directions

Administer the infusion as directed by a healthcare professional. It is important to follow the recommended dosage and infusion rate to ensure safety and efficacy.

Scientific Evidence

Studies have shown that Ibandronic acid is effective in reducing the risk of fractures and improving bone mineral density in postmenopausal women with osteoporosis. Research published in the Journal of Bone and Mineral Research supports the use of Ibandronic acid in the management of osteoporosis.

Additional Information

It is important to monitor calcium levels and kidney function during treatment with Ibandronic acid. Inform your healthcare provider about any other medications or supplements you are taking to avoid potential interactions.

Ibandronic acid works by inhibiting bone resorption, leading to increased bone mineral density and reduced fracture risk. It is a potent bisphosphonate that specifically targets osteoclasts, the cells responsible for breaking down bone tissue.

Clinical trials have demonstrated the efficacy of Ibandronic acid in reducing the incidence of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis. Compared to other bisphosphonates, Ibandronic acid has shown similar effectiveness with a favorable safety profile.